Related Experiment Video
Updated: Apr 8, 2026
05:57
Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases
Published on: August 2, 2022
5.3K
Serum eye drop preparation in Australia: Current manufacturing practice
Denese C Marks1, Jenny Fisher1, Phillip Mondy1
1The Australian Red Cross Blood Service, Sydney, Australia.
Summary
Autologous serum eye drops offer a therapeutic option for severe dry eye disease when conventional treatments fail. Manufacturing involves processing patient blood into eye drops, meeting rising demand in Australia.
Area of Science:
- Ophthalmology
- Blood Product Manufacturing
Background:
- Dry eye syndrome (keratoconjunctivitis sicca) causes an unstable tear film.
- Conventional treatments like artificial tears and immunosuppressants may not be effective.
- Autologous serum eye drops are a treatment option for refractory dry eye disease.
Purpose of the Study:
- To describe the process and increasing demand for autologous serum eye drops in Australia.
Main Methods:
- Whole blood is collected from patients.
- Blood is clotted to yield serum, processed into 20% eye drops.
- Eye drops are packaged into single-use segments.
Main Results:
- Autologous serum eye drops are manufactured for patients unresponsive to other therapies.
- Demand for these eye drops has increased by 30% in the last 12 months.
Conclusions:
- Autologous serum eye drops are an important treatment for dry eye syndrome.
- The increasing demand highlights their clinical significance and patient need.
